Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

BACKGROUND: Despite the availability of effective systemic therapies, a significant number of advanced melanoma patients develops brain metastases. This study investigated differences in incidence and time to diagnosis of brain metastasis and survival outcomes dependent on the type of first-line the...

Descripción completa

Detalles Bibliográficos
Autores principales: Franklin, Cindy, Mohr, Peter, Bluhm, Leonie, Meier, Friedegund, Garzarolli, Marlene, Weichenthal, Michael, Kähler, Katharina, Grimmelmann, Imke, Gutzmer, Ralf, Utikal, Jochen, Terheyden, Patrick, Herbst, Rudolf, Haferkamp, Sebastian, Pfoehler, Claudia, Forschner, Andrea, Leiter, Ulrike, Ziller, Fabian, Meiss, Frank, Ulrich, Jens, Kreuter, Alexander, Gebhardt, Christoffer, Welzel, Julia, Schilling, Bastian, Kaatz, Martin, Scharfetter-Kochanek, Karin, Dippel, Edgar, Nashan, Dorothee, Sachse, Michael, Weishaupt, Carsten, Löffler, Harald, Gambichler, Thilo, Loquai, Carmen, Heinzerling, Lucie, Grabbe, Stephan, Debus, Dirk, Schley, Gaston, Hassel, Jessica C, Weyandt, Gerhard, Trommer, Maike, Lodde, Georg, Placke, Jan-Malte, Zimmer, Lisa, Livingstone, Elisabeth, Becker, Jürgen Christian, Horn, Susanne, Schadendorf, Dirk, Ugurel, Selma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083858/
https://www.ncbi.nlm.nih.gov/pubmed/37028819
http://dx.doi.org/10.1136/jitc-2022-005828

Ejemplares similares

Ejemplares similares